Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Inflammatory Bowel Disease Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Inflammatory Bowel Disease Therapeuticsmarket, defines the market attractiveness level of Inflammatory Bowel Disease Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Inflammatory Bowel Disease Therapeutics industry, describes the types of Inflammatory Bowel Disease Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Inflammatory Bowel Disease Therapeutics market and the development prospects and opportunities of Inflammatory Bowel Disease Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Inflammatory Bowel Disease Therapeutics market in Chapter 13.
By Player:
Novartis
GlaxoSmithKline
Johnson & Johnson
Abbvie
Merck
By Type:
Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory drugs (NSAIDs)
Corticosteroids
By End-User:
Solid
Liquid
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Inflammatory Bowel Disease Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Inflammatory Bowel Disease Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Inflammatory Bowel Disease Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Inflammatory Bowel Disease Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Inflammatory Bowel Disease Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Inflammatory Bowel Disease Therapeutics Consumption (2017-2022)
-
7.2 United States Inflammatory Bowel Disease Therapeutics Consumption (2017-2022)
-
7.3 Europe Inflammatory Bowel Disease Therapeutics Consumption (2017-2022)
-
7.4 China Inflammatory Bowel Disease Therapeutics Consumption (2017-2022)
-
7.5 Japan Inflammatory Bowel Disease Therapeutics Consumption (2017-2022)
-
7.6 India Inflammatory Bowel Disease Therapeutics Consumption (2017-2022)
-
7.7 South Korea Inflammatory Bowel Disease Therapeutics Consumption (2017-2022)
8 Region and Country-wise Inflammatory Bowel Disease Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Inflammatory Bowel Disease Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Inflammatory Bowel Disease Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Inflammatory Bowel Disease Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Inflammatory Bowel Disease Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Inflammatory Bowel Disease Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Inflammatory Bowel Disease Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Inflammatory Bowel Disease Therapeutics Consumption Forecast (2022-2028)
9 Global Inflammatory Bowel Disease Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Inflammatory Bowel Disease Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Anti-inflammatory Biologics Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Non-Steroidal Anti-inflammatory drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Corticosteroids Consumption and Growth Rate (2017-2022)
-
9.2 Global Inflammatory Bowel Disease Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Solid Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Liquid Consumption and Growth Rate (2017-2022)
10 Global Inflammatory Bowel Disease Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Inflammatory Bowel Disease Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Anti-inflammatory Biologics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Non-Steroidal Anti-inflammatory drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Inflammatory Bowel Disease Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Solid Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Liquid Consumption Forecast and Growth Rate (2022-2028)
11 Global Inflammatory Bowel Disease Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Inflammatory Bowel Disease Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Inflammatory Bowel Disease Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Inflammatory Bowel Disease Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Inflammatory Bowel Disease Therapeutics Market Competitive Analysis
-
14.1 Novartis
-
14.1.1 Novartis Company Details
-
14.1.2 Novartis Inflammatory Bowel Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis Inflammatory Bowel Disease Therapeutics Product and Service
-
14.2 GlaxoSmithKline
-
14.2.1 GlaxoSmithKline Company Details
-
14.2.2 GlaxoSmithKline Inflammatory Bowel Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 GlaxoSmithKline Inflammatory Bowel Disease Therapeutics Product and Service
-
14.3 Johnson & Johnson
-
14.3.1 Johnson & Johnson Company Details
-
14.3.2 Johnson & Johnson Inflammatory Bowel Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Johnson & Johnson Inflammatory Bowel Disease Therapeutics Product and Service
-
14.4 Abbvie
-
14.4.1 Abbvie Company Details
-
14.4.2 Abbvie Inflammatory Bowel Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Abbvie Inflammatory Bowel Disease Therapeutics Product and Service
-
14.5 Merck
-
14.5.1 Merck Company Details
-
14.5.2 Merck Inflammatory Bowel Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Merck Inflammatory Bowel Disease Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Inflammatory Bowel Disease Therapeutics
-
Figure Inflammatory Bowel Disease Therapeutics Picture
-
Table Global Inflammatory Bowel Disease Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Inflammatory Bowel Disease Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Inflammatory Bowel Disease Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Inflammatory Bowel Disease Therapeutics Consumption by Country (2017-2022)
-
Figure United States Inflammatory Bowel Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Inflammatory Bowel Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Inflammatory Bowel Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Inflammatory Bowel Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Inflammatory Bowel Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Inflammatory Bowel Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Inflammatory Bowel Disease Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Inflammatory Bowel Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Inflammatory Bowel Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Inflammatory Bowel Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Inflammatory Bowel Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Inflammatory Bowel Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Inflammatory Bowel Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-inflammatory Biologics Consumption and Growth Rate (2017-2022)
-
Figure Global Non-Steroidal Anti-inflammatory drugs (NSAIDs) Consumption and Growth Rate (2017-2022)
-
Figure Global Corticosteroids Consumption and Growth Rate (2017-2022)
-
Figure Global Solid Consumption and Growth Rate (2017-2022)
-
Figure Global Liquid Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-inflammatory Biologics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-Steroidal Anti-inflammatory drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Solid Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Liquid Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Inflammatory Bowel Disease Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Inflammatory Bowel Disease Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Inflammatory Bowel Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Inflammatory Bowel Disease Therapeutics Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Inflammatory Bowel Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Inflammatory Bowel Disease Therapeutics Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Inflammatory Bowel Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Inflammatory Bowel Disease Therapeutics Product and Service
-
Table Abbvie (Foundation Year, Company Profile and etc.)
-
Table Abbvie Inflammatory Bowel Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbvie Inflammatory Bowel Disease Therapeutics Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Inflammatory Bowel Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Inflammatory Bowel Disease Therapeutics Product and Service
-
